1 min read
Add as a preferred source on Google

Insmed Raises Brinsupri Sales Forecast Floor by $100 Million

Brinsupri is now projected to bring in $1.35 billion to $1.4 billion for the full year, compared with a prior range of $1.25 billion to $1.4 billion.

An amber medicine bottle and capsule on a raised stone step / TokenPost.ai
An amber medicine bottle and capsule on a raised stone step / TokenPost.ai

Insmed lifted the low end of its full-year Brinsupri sales forecast by $100 million after third-quarter revenue exceeded estimates, while shares climbed about 13% in Thursday trading.

The updated forecast is $1.35 billion to $1.4 billion, compared with a prior range of $1.25 billion to $1.4 billion. The upper end remained unchanged.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…